Having placed executives into these roles repeatedly, we wrote this to tell you what genuinely matters, not the generic career advice you have already read. Recruiters working pharmaceutical searches spend most of their time managing avoidable friction: candidates who misunderstand the process, present themselves imprecisely, or conceal things that will surface later. Understanding how the process actually works from the recruiter’s side makes you both easier to represent and more likely to be presented.
Key Takeaways
- The recruiter works for the client but can advocate for you.
- Precision about your own contribution is unusually persuasive.
- Concealment is the fastest way to lose a candidacy.
- Therapeutic area and modality fit matter more than candidates expect.
- Responsiveness and reliability affect how you are represented.
Understand Whose Interests Are Whose
A retained recruiter is engaged and paid by the hiring company, so their obligation runs to the client. That does not make them indifferent to you, since their credibility depends on presenting candidates who succeed, but it does mean they will not market you generally or advocate against the client’s interests. Candidates who understand this engage more productively: they treat the recruiter as a knowledgeable intermediary whose interest is a good match, rather than as either an agent or an obstacle. That framing produces better information flow in both directions.
Be Precise About What You Did
Pharmaceutical outcomes are produced by large cross-functional teams over years, and recruiters spend considerable effort establishing what a candidate actually contributed. Candidates who volunteer this precision, what they owned, what decisions were theirs, what they would attribute to colleagues or circumstance, are markedly easier to present and more credible when references are taken. Candidates who describe programme outcomes in expansive first-person terms create a gap between their account and their references that damages them more than modest framing ever would.
Disclose Early
Departures that were not entirely voluntary, gaps, programme failures, and disagreements are common in pharmaceutical careers and are rarely disqualifying in themselves. What damages candidacies is discovering them late, because the recruiter has already represented a picture to the client that turns out to be incomplete. Disclosing early lets the recruiter frame the situation properly and prepare the client, which usually neutralises it entirely. Concealment converts a manageable fact into a credibility problem, and recruiters see this pattern constantly.
Fit Is More Specific Than You Think
Candidates frequently express frustration at not being considered despite strong pharmaceutical credentials, when the brief requires a specific therapeutic area, modality, company stage, or regulatory experience they do not have. Pharmaceutical fit is genuinely narrow: an oncology development leader and an immunology one are not interchangeable, nor are large pharma and clinical-stage biotech backgrounds. Understanding this reduces frustration and helps you target roles where you are genuinely competitive rather than pursuing ones where the brief was never going to fit.
Reliability Shapes Representation
Practical conduct matters more than candidates expect. Responding promptly, honouring scheduling commitments, giving straight answers about compensation expectations and competing processes, and communicating changes in your situation all make a recruiter more confident representing you. Recruiters are staking their credibility on the candidates they put forward, and one who is difficult to schedule, vague about their situation, or unpredictable becomes a risk. Being straightforward and reliable is a genuine advantage that costs nothing.
What This Looks Like in Practice
A candidate working with pharmaceutical recruiters treats them as knowledgeable intermediaries seeking a good match, volunteers precision about their own contribution, discloses difficulties early enough for the recruiter to frame them, targets roles where therapeutic and stage fit are genuine, and is responsive and straightforward throughout.
The Mistake Candidates Keep Making
The most common mistake is presenting an inflated or smoothed account, expansive credit for team outcomes and silence about a difficult departure, on the theory that the recruiter is an obstacle to get past. Recruiters verify, and the correction damages the candidacy far more than the original facts would have. The candidate manages the intermediary instead of equipping them.
What Makes You Easy to Represent
| Behaviour | Effect |
|---|---|
| Precision about your contribution | Survives reference checking |
| Early disclosure of difficulties | Lets the recruiter frame them |
| Realistic targeting | Avoids wasted effort on poor fits |
| Prompt, straight communication | Reduces the recruiter’s risk |
| Clarity on compensation and competing processes | Prevents late surprises |
The Bottom Line
Pharmaceutical recruiters can advocate for you within a client’s brief but not against it, so be precise about your actual contribution, disclose difficulties early enough to be framed properly, target roles where therapeutic and stage fit are real, and be reliable, since all of it makes you easier to represent. None of this is quick, but it compounds, and the candidates who start early are the ones with options later.
Related Reading
For more, see Preparing for a Pharma C-Suite Interview, Building Your Network in the Pharmaceutical Industry, Resume Strategies for Pharma Regulatory Affairs Professionals.
Frequently Asked Questions
- Q: Does a retained recruiter work for me?
- A: No; they are engaged and paid by the hiring company, though their credibility depends on presenting candidates who succeed, so their interest is a genuine match.
- Q: Why does precision about contribution matter?
- A: Because pharmaceutical outcomes come from large teams over years, and expansive first-person accounts create gaps with references that damage candidacies badly.
- Q: Should I disclose a difficult departure?
- A: Yes, early; such facts are rarely disqualifying in themselves, but discovering them late undermines the picture the recruiter has already presented to the client.
- Q: Why am I not considered despite strong credentials?
- A: Because pharmaceutical fit is genuinely narrow, therapeutic area, modality, company stage, and regulatory experience are not interchangeable, so briefs are more specific than they appear.
- Q: Does responsiveness really matter?
- A: Yes; recruiters stake their credibility on candidates they present, so being difficult to schedule or vague about your situation makes you a risk they may avoid.
![](https://www.jrgpartners.com/wp-content/uploads/2025/12/tanya-gallardo.jpeg")
Tanya Gallardo
Managing Director, Executive Search & AI Talent Strategy
Tanya Gallardo is the Managing Director of Executive Search & AI Talent Strategy at JRG Partners, leading C-suite and Board engagements across key growth sectors including Technology, Financial Services, and Manufacturing.
With over 18 years of experience specializing in disruptive technology leadership, Tanya is recognized as a leading authority on talent architecture for future-focused executive roles, such as the Chief AI Officer (CAIO) and Chief Digital Officer (CDO). Her expertise lies in accurately assessing the cultural fit and technical depth required to ensure a high return on investment (ROI) for critical leadership appointments.
Prior to her role at JRG Partners, Tanya held senior roles directing global talent acquisition strategies at a major publicly-traded technology firm, advising on organizational design and succession planning for emerging executive functions. She is a recognized speaker and contributor to industry events, sharing data-driven insights on executive compensation, leadership development, and the measurable business impact of C-suite talent.
